TP53 Mutations in High Risk Myelodysplastic Syndromes Patients Treated with Azacitidine According to Cetlam Group Protocol. (April 2017)

Record Type:
Journal Article
Title:
TP53 Mutations in High Risk Myelodysplastic Syndromes Patients Treated with Azacitidine According to Cetlam Group Protocol. (April 2017)
Main Title:
TP53 Mutations in High Risk Myelodysplastic Syndromes Patients Treated with Azacitidine According to Cetlam Group Protocol
Authors:
Cabezón, M.
Bargay, J.
Xicoy, B.
García, O.
Tormo, M.
Palomo, L.
Marcé, S.
Valcárcel, D.
Pedro, C.
Jiménez, M.J.
Borràs, J.
Guàrdia, R.
Brunet, S.
Martí, J.M.
Garcia, A.
Zamora, L.
Abstract:
Is Part Of:
Leukemia research. Volume 55(2017)Supplement 1
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Issue Display:
Volume 55, Issue 1 (2017)
Year:
2017
Volume:
55
Issue:
1
Issue Sort Value:
2017-0055-0001-0000
Page Start:
S155
Page End:
Publication Date:
2017-04
Subjects:
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:
http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0145-2126(17)30383-1 ↗
Languages:
English
ISSNs:
0145-2126
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
438.xml